Charles Crump
Internal Medicine · Chattanooga, TNNPI 1093704744
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $459 and has fallen 94.9% since, to $23 in 2024.
Across 49 payments — averaging $14.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$154
- Novartis$78
- Amgen$73
- AbbVie$69
- Boehringer Ingelheim$55
- Abbott$41
- plus $231 from 11 others
Across 618 payments — averaging $1638.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$541K
- Novo Nordisk AS$300K
- AbbVie$129K
- Kowa Research Institute, Inc.$31K
- Alnylam Pharmaceuticals Inc.$11K
What the payments were for
- Food & beverage$702100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 15 | $154 |
| Novartis | 4 | $78 |
| Amgen | 4 | $73 |
| AbbVie | 4 | $69 |
| Boehringer Ingelheim | 4 | $55 |
| Abbott | 2 | $41 |
| AstraZeneca | 3 | $38 |
| Amarin Pharma, Inc. | 2 | $34 |
| Sanofi-aventis U.S. LLC | 2 | $28 |
| Pfizer | 2 | $24 |
| Eisai Inc. | 1 | $22 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Ironshore Pharmaceuticals Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Medtronic | 1 | $13 |
| GSK | 1 | $12 |
| Boston Scientific | 1 | $11 |
How this compares
$702 in reported general payments places this provider in the 65th percentile of 2,216 internal medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breo ElliptaFluticasone/Vilanterol | 13 | $4,129 |
| Esomeprazole Magnesium | 34 | $2,977 |
| Novolog FlexpenInsulin Aspart | 17 | $2,806 |
| ValacyclovirValacyclovir Hcl | 28 | $2,134 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 22 | $1,905 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 51 | $1,410 |
| Atorvastatin Calcium | 76 | $1,127 |
| Rosuvastatin Calcium | 90 | $1,051 |
| Testosterone Cypionate | 20 | $1,042 |
| Ezetimibe | 24 | $944 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 35 | $784 |
| Metoprolol Succinate | 37 | $755 |
| Levothyroxine Sodium | 86 | $753 |
| Losartan Potassium | 63 | $720 |
| SynthroidLevothyroxine Sodium | 11 | $716 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta | $12 | $4,12913 claims |
| AbbVieSynthroid | $69 | $71611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,216 internal medicine providers in Tennessee.
Other internal medicine in Chattanooga
- Maighan SeagroveChattanooga$78K
- Carlton VollbergChattanooga$30K
- Jeremy HogstromChattanooga$30K
- Jermaine HogstromChattanooga$29K
- Eugene RyanChattanooga$26K
- John AndersonNashville$1.5M
- Tracie WalkerJackson$488K
- Nathan TrenthamEtowah$404K
- Dennis DeruelleKnoxville$263K
- Devin ShermanFranklin$191K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.